3-(3,5-dimethylphenyl)-3'-trifluoromethylpropiophenone, 97.0%, 1g

Benzyl phenyl ether, 95.0%, 25g

Balance d'analyse et de précision Série Entris® II Modèles avec réglage interne, non certifiés, 0,0001 g, 60 g, BCE64i-1S (W)

1-((2'-Cyano-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1h-benzo[d]imidazole-7-carboxylic acid, 97%, 1g

2-Aminoisobutyric acid, 98.0%, 250g

(3R,4S,5S,6S)-6-(METHOXYCARBONYL)TETRAHYDRO-2H-PYRAN-2,3,4,5-TETRAYL TETRAACETATE, 95.0%, 10g

4,6-Dimethyl-2-(methylthio)pyrimidine, 95.0%, 100g

3-BROMO-2-(METHYLTHIO)PYRIDINE, 95%, 250mg

(11bS)-3,5-Bis(2,2-dimethylbutyl)-4,5-dihydro-3H-dinaphtho[2,1-d:1',2'-f][1,3,2]diazaphosphepine 4-oxide, 98%, 50mg

Ethyl 5-benzyl-4H-1,2,4-triazole-3-carboxylate, 97%, 5g

Benzenesulfonamide, 4-dodecyl-N-1,3,4-thiadiazol-2-yl-, 98%, 10mg

1-Methylsulfonyl-2,2-dimethylpiperazine hydrochloride, 97%, 5g

Hydroxyadamantanone, min.98%, pour la synthèse, 5 g, emballage en verre